Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
NCT01723371Phase 2Withdrawn
- Sponsor
- SickKids
- Start
- Sep 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in pulmonary arterial hypertension (PAH), sponsored by SickKids. Planned start Sep 2012; status: withdrawn.
02
Drugs
carvedilol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01723371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01723371.